1.13

1.74% -0.02

After Hours: 1.12 -0.010 -0.88%

Cocrystal Pharma Inc (COCP)

Overview News Price History Financials Discussions Forecast Stock Split

Cocrystal Pharma Inc stock is traded at $1.13, with a volume of 348.45K. It is down -1.74% in the last 24 hours and down -20.98% over the past month. Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Previous Close:

$1.15

Open:

$1.26

24h Volume:

348.45K

Relative Volume:

0.15

Market Cap:

$15.58M

Revenue:

Net Income/Loss:

$-8.83M

P/E Ratio:

-1.4293

EPS:

-0.7906

Net Cash Flow:

$-8.61M

1W Performance:

-1.74%

1M Performance:

-20.98%

6M Performance:

+11.88%

1Y Performance:

-22.60%

1-Day Range:

$1.13

$1.26

1-Week Range:

$1.08

$1.26

52-Week Range:

$0.8588

$2.67

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name

Cocrystal Pharma Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

(786) 459-1831

Address

19805 N. CREEK PARKWAY, BOTHELL, WA

Employee

Twitter

@cocrystalpharma

Next Earnings Date

2026-05-21

Latest SEC Filings

COCP's Discussions on Twitter

Compare COCP vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COCP Cocrystal Pharma Inc	1.13	15.86M	0	-8.83M	-8.61M	-0.7906
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-20	Initiated	H.C. Wainwright	Buy

Cocrystal Pharma Inc Stock (COCP) Latest News

09:45 AM

Cocrystal Pharma (NASDAQ: COCP) highlights pan-viral inhibitor data and Phase 1b progress - Stock Titan

08:30 AM

08:00 AM

Deadly cruise ship hantavirus; Cocrystal runs lab tests on pan-viral blockers - Stock Titan

08:00 AM

May 21, 2026

Cocrystal Pharma Stock Slips: Why COCP’s Norovirus Bet Is Back in Focus - Bez Kabli

May 21, 2026

May 20, 2026

Cocrystal (COCP) Q1 2026 Earnings Miss by Significant: Key TakeawaysMargin Compression Risk - Newser

May 20, 2026

May 18, 2026

Why Is Cocrystal Pharma, Inc. (COCP) Stock Down Today? - Meyka

May 18, 2026

May 15, 2026

Cocrystal (COCP) Declines -3.57% Amid Market Weakness 2026-05-15Market Neutral Pair - newser.com

May 15, 2026

Cocrystal Pharma, Inc. 2026 Q1 Financials: Company Overview, Segment Information, and Going Concern Risks - Minichart

May 15, 2026

Cocrystal Pharma Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026

Cocrystal Pharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2026

Cocrystal Pharma, Inc. 1Q 2026: Net loss $(2.30M), No revenue — 10-Q Summary - TradingView

May 15, 2026

Cocrystal Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026

[10-Q] Cocrystal Pharma, Inc. Quarterly Earnings Report - Stock Titan

May 15, 2026

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewswire

May 15, 2026

May 14, 2026

Number of shareholders of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView

May 14, 2026

May 13, 2026

Number of shareholders of Cocrystal Pharma Inc – LS:A3DWYX - TradingView

May 13, 2026

May 11, 2026

What Cocrystal (COCP) is building for next year | Q4 2025: EPS Exceeds ExpectationsSlow Growth - newser.com

May 11, 2026

Cocrystal Pharma Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView

May 11, 2026

May 04, 2026

[EFFECT] Cocrystal Pharma, Inc. SEC Filing - Stock Titan

May 04, 2026

May 01, 2026

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection - The Manila Times

May 01, 2026

Apr 30, 2026

Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026 - TipRanks

Apr 30, 2026

Cocrystal Pharma (COCP) advances Fast Track CDI-988 in Phase 1b norovirus challenge study - Stock Titan

Apr 30, 2026

No approved norovirus drugs; Cocrystal tests oral CDI-988 - Stock Titan

Apr 30, 2026

Apr 28, 2026

COCP stock soars 75% — what is the link to Cocrystal’s norovirus treatment? - MSN

Apr 28, 2026

Apr 23, 2026

Cocrystal Pharma Incfiles to offer up to $150 million in securitiesSEC filing - marketscreener.com

Apr 23, 2026

Cocrystal Pharma (NASDAQ: COCP) files $150M shelf to offer stock and warrants - Stock Titan

Apr 23, 2026

Apr 22, 2026

COCP: Q4 2025 Earnings: Cocrystal Pharma Inc. posts 4.8% EPS beat with no Q4 revenueTop Analyst Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Cocrystal (COCP) Stock: Why Efficiency Gains (Momentum Building) 2026-04-22RSI Oversold Stocks - Xã Vĩnh Công

Apr 22, 2026

Apr 17, 2026

Why Cocrystal Pharma Shares Are Cooling Off Monday? - MSN

Apr 17, 2026

Apr 16, 2026

Form 8-KCurrent report - ADVFN

Apr 16, 2026

Apr 15, 2026

Cocrystal Pharma (COCP) price target increased by 33.33% to 8.16 - MSN

Apr 15, 2026

Apr 13, 2026

Smart Money: Can Cocrystal Pharma Inc deliver consistent EPS growth2026 Technical Patterns & Daily Growth Stock Tips - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Investor Mood: Is Cocrystal Pharma Inc benefiting from innovation trendsQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Apr 10, 2026

What events could move Cocrystal (COCP) Stock next | Price at $1.29, Down 9.79%Factor Momentum - Newser

Apr 10, 2026

Apr 08, 2026

Tech Rally: Is Cocrystal Pharma Inc stock risky to hold nowMarket Activity Summary & Consistent Profit Trading Strategies - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention - Zacks Small Cap Research

Apr 07, 2026

Apr 05, 2026